Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Jackson

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
The Annals of Occupational Hygiene|March 13, 2009
A novel size-selective airborne particle size fractionating instrument for health risk evaluationB Gorbunov, N D Priest, R B Muir, et al.
Journal of Hypertension|May 2, 2001
Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validationE J Wallis, L E Ramsay, I U Haq, et al.
British Journal of Clinical Pharmacology|March 1, 1995
Effect of dose adjustment on enalapril-induced cough and the response to inhaled capsaicinW W Yeo, K S Higgins, G Foster, et al.
British Journal of Clinical Pharmacology|November 1, 1995
Resolution of ACE inhibitor cough: changes in subjective cough and responses to inhaled capsaicin, intradermal bradykinin and substance-PW W Yeo, I G Chadwick, M Kraskiewicz, et al.
BMJ (Clinical Research Ed.)|October 31, 1998
Cholestanol and survival with simvastatin. More data are neededE J Wallis, R Williamson, L E Ramsay, et al.
Lancet (London, England)|January 15, 1998
Drug therapy for coronary heart disease: the Sheffield tableE J Wallis, L E Ramsay, P R Jackson, et al.
Clinical Science (London, England : 1979)|April 1, 1985
Is the urinary excretion of prostaglandin E in man dependent on urine pH?J Haylor, J M Toner, P R Jackson, et al.
Clinical Pharmacology and Therapeutics|April 29, 1998
Protein binding of aspirin and salicylate measured by in vivo ultrafiltrationP Ghahramani, K Rowland-Yeo, W W Yeo, et al.
Heart (British Cardiac Society)|February 17, 2001
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trialsP S Sanmuganathan, P Ghahramani, P R Jackson, et al.
Journal of Human Hypertension|February 1, 1995
Pressor effect of hyperventilation in healthy subjectsG P Todd, I G Chadwick, W W Yeo, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
The Annals of Occupational Hygiene|March 13, 2009
A novel size-selective airborne particle size fractionating instrument for health risk evaluationB Gorbunov, N D Priest, R B Muir, et al.
Journal of Hypertension|May 2, 2001
Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validationE J Wallis, L E Ramsay, I U Haq, et al.
British Journal of Clinical Pharmacology|March 1, 1995
Effect of dose adjustment on enalapril-induced cough and the response to inhaled capsaicinW W Yeo, K S Higgins, G Foster, et al.
British Journal of Clinical Pharmacology|November 1, 1995
Resolution of ACE inhibitor cough: changes in subjective cough and responses to inhaled capsaicin, intradermal bradykinin and substance-PW W Yeo, I G Chadwick, M Kraskiewicz, et al.
BMJ (Clinical Research Ed.)|October 31, 1998
Cholestanol and survival with simvastatin. More data are neededE J Wallis, R Williamson, L E Ramsay, et al.
Lancet (London, England)|January 15, 1998
Drug therapy for coronary heart disease: the Sheffield tableE J Wallis, L E Ramsay, P R Jackson, et al.
Clinical Science (London, England : 1979)|April 1, 1985
Is the urinary excretion of prostaglandin E in man dependent on urine pH?J Haylor, J M Toner, P R Jackson, et al.
Clinical Pharmacology and Therapeutics|April 29, 1998
Protein binding of aspirin and salicylate measured by in vivo ultrafiltrationP Ghahramani, K Rowland-Yeo, W W Yeo, et al.
Heart (British Cardiac Society)|February 17, 2001
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trialsP S Sanmuganathan, P Ghahramani, P R Jackson, et al.
Journal of Human Hypertension|February 1, 1995
Pressor effect of hyperventilation in healthy subjectsG P Todd, I G Chadwick, W W Yeo, et al.
Pageof 14